2012
DOI: 10.1100/2012/412580
|View full text |Cite
|
Sign up to set email alerts
|

SPECT and PET Imaging of Meningiomas

Abstract: Meningiomas arise from the meningothelial cells of the arachnoid membranes. They are the most common primary intracranial neoplasms and represent about 20% of all intracranial tumors. They are usually diagnosed after the third decade of life and they are more frequent in women than in men. According to the World Health Organization (WHO) criteria, meningiomas can be classified into grade I meningiomas, which are benign, grade II (atypical) and grade III (anaplastic) meningiomas, which have a much more aggressi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
27
0
2

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(29 citation statements)
references
References 85 publications
0
27
0
2
Order By: Relevance
“…Radionuclides also have been made to target somatostatin receptors, which are expressed in meningiomas. Indium-111–labeled octreotide, as well as technetium-99m–labeled depreotide, have been used with single-photon emission CT to image meningiomas, 31 with gallium-68–labeled DOTA-D-Phe1-Tyr3-octreotide, which has a high affinity for the somatostatin receptor subtype 2 (SSTR 2), used with PET to image meningiomas. The high tumor-to-background ratio, along with the advent of hybrid PET and MRI systems, allow for highly sensitive and specific diagnosis of intracranial meningiomas.…”
Section: Nuclear Medicinementioning
confidence: 99%
“…Radionuclides also have been made to target somatostatin receptors, which are expressed in meningiomas. Indium-111–labeled octreotide, as well as technetium-99m–labeled depreotide, have been used with single-photon emission CT to image meningiomas, 31 with gallium-68–labeled DOTA-D-Phe1-Tyr3-octreotide, which has a high affinity for the somatostatin receptor subtype 2 (SSTR 2), used with PET to image meningiomas. The high tumor-to-background ratio, along with the advent of hybrid PET and MRI systems, allow for highly sensitive and specific diagnosis of intracranial meningiomas.…”
Section: Nuclear Medicinementioning
confidence: 99%
“…Meningeome | Ein großer Anteil primärer ZNS-Tumore sind Meningeome [26]. Eine nuklearmedizinische Diagnostik mittels SPECT -obwohl noch nicht routinemäßig verwendet -kann ergänzende diagnostische Informationen zur CT und MRT liefern.…”
Section: Weitere Indikationenunclassified
“…Auf diese Weise kann festgestellt werden, ob Patienten für eine Radiopeptidtherapie in Frage kommen (▶ Abb. 3) [26][27][28]. [16].…”
Section: Weitere Indikationenunclassified
“…Tc-99m tetrofosmin is commonly used for myocardial perfusion imaging agent, mainly at Harapan Kita Cardiac Hospital, Jakarta and Hasan Sadikin General Hospital, Bandung [1]. However, in recent year the use of Tc-99m tetrofosmin has been expanding not only for myocardial imaging but also for detection of several tumors and cancers such as brain cancer (glioma, glioblastoma, and meningioma), breast cancer and parathyroid adenoma [2][3][4][5]. The chemical structure of Tc-99m tetrofosmin has been discussed elsewhere [6].…”
Section: Introductionmentioning
confidence: 99%